Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease.
Zhang Y, Shen L, Dreißigacker K, Zhu H, Trinh-Minh T, Meng X, Tran-Manh C, Dees C, Matei AE, Chen CW, Ditschkowski M, Krauss S, Winkler J, Wolff D, Ziemer M, Beilhack A, Karrer S, Herr W, Mackensen A, Schett G, Spriewald BM, Distler JHW.
Zhang Y, et al. Among authors: winkler j.
Blood. 2021 Apr 29;137(17):2403-2416. doi: 10.1182/blood.2020008720.
Blood. 2021.
PMID: 33529322
Free article.